Sign in

CIK 0001894562

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Prime Medicine, Inc.

Sign in to watch
Ticker
PRME
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-465-0013
Business address
60 FIRST ST., CAMBRIDGE, MA, 02141
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-02-23 LEE ANN L. Chief Technical Officer Grant or award · Stock Option (right to buy) +375,000 375,000
2025-08-01 LEE ANN L. Chief Technical Officer Returned to the company · Stock Option (right to buy) −180,995 0
2025-08-01 LEE ANN L. Chief Technical Officer Grant or award · Stock Option (right to buy) +180,995 180,995
2025-08-01 LEE ANN L. Chief Technical Officer Returned to the company · Stock Option (right to buy) −180,995 0
2025-08-01 LEE ANN L. Chief Technical Officer Grant or award · Stock Option (right to buy) +180,995 180,995
2025-05-21 LEE ANN L. Chief Technical Officer Purchase +100,000 $1.13 $113K 100,000
2025-05-08 LEE ANN L. Chief Technical Officer Grant or award · Stock Option (right to buy) +80,416 241,248
2025-02-27 LEE ANN L. Chief Technical Officer Grant or award · Stock Option (right to buy) +275,000 275,000
2024-05-17 LEE ANN L. Chief Technical Officer Grant or award · Stock Option (right to buy) +80,416 160,832
2024-02-21 LEE ANN L. Chief Technical Officer Grant or award · Stock Option (right to buy) +180,995 180,995
2023-03-31 LEE ANN L. Chief Technical Officer Grant or award · Stock Option (right to buy) +180,995 180,995

Page 1 of 1 · 11 trades